Table 1.
Key characteristics of eligible trials.
| Number of eligible studies | 163 |
| Range of publication years | 1982–2017 |
| Study type # | |
| Singly tested small molecules | 82 |
| Singly tested biologics | 21 |
| Biologics and/or small molecules in combination | 29 |
| Surgical intervention | 16 |
| Radiation therapy | 27 |
| Dietary regimen/feeding behavior | 8 |
| Diagnostic procedure | 1 |
| Number of studies per ACS tumor type* | |
| Bone | 32 |
| Digestive | 12 |
| Endocrine | 5 |
| Eye | 3 |
| Genital | 10 |
| Leukemia | 2 |
| Lymphoma | 53 |
| Mammary | 28 |
| Mastocytoma | 22 |
| Nervous | 8 |
| Not reported | 23 |
| Oral | 19 |
| Other | 25 |
| Respiratory | 4 |
| Skin | 27 |
| Soft tissue | 29 |
| Urinary | 12 |
*Each trial may have investigated multiple tumor types.
#Each trial may have investigated multiple intervention types.